Salarius Pharmaceuticals Inc(SLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SLRX Salarius Pharmaceuticals Inc

盘前交易 07-22 07:53:00 EDT

1.83

-0.60

-24.85%

盘前1.64

-0.19-10.38%

07:27 EDT

最高2.32	最低1.75	成交量96.79万
今开2.32	昨收2.44	日振幅23.55%
总市值109.27万	流通市值109.27万	总股本59.71万
成交额193.03万	换手率162.11%	流通股本59.71万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SLRX","market":"US","secType":"STK","nameCN":"Salarius Pharmaceuticals Inc","latestPrice":1.83,"timestamp":1721419200000,"preClose":2.435,"halted":0,"volume":967948,"hourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.83,"latestTime":"07:27 EDT","volume":713,"amount":1177.3900192,"timestamp":1721647666274},"delay":0,"floatShares":597100,"shares":597100,"eps":-19.201153,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.605,"latestTime":"07-22 07:53:00 EDT","open":2.32,"high":2.3235,"low":1.75,"amount":1930281.5144208,"amplitude":0.235524,"askPrice":1.91,"askSize":200,"bidPrice":1.57,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-19.201153,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1422507600000,"adjPreClose":1.83,"preHourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.83,"latestTime":"07:27 EDT","volume":713,"amount":1177.3900192,"timestamp":1721647666274},"postHourTrading":{"tag":"盘后","latestPrice":1.7002,"preClose":1.83,"latestTime":"19:58 EDT","volume":33009,"amount":57491.7048,"timestamp":1721433509167},"volumeRatio":0.20881877858100112},"requestUrl":"/m/hq/s/SLRX/tweets","defaultTab":"tweets","newsList":[{"id":"2452305284","title":"BUZZ-Salarius Pharma 因终止早期骨癌研究而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2452305284","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452305284?lang=zh_cn&edition=full","pubTime":"2024-07-20 05:46","pubTimestamp":1721425586,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月19日 - ** 药物开发商Salarius Pharmaceuticals   股价盘后下跌4.4%至1.75美元 ** 该公司将结束正在对一种骨癌患者进行的实验性药物seclidemstat的早期试验** 该公司表示，在董事会继续探索潜在战略选择的同时，公司将结束这项研究，以节省现金。** 7月11日，美国食品及药物管理局（FDA）对 (link) 另一项在血癌患者中测试 seclidemstat 的癌症研究实施了部分临床暂停。 ** 截至最后收盘，股价年累计下跌64.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","SLRX"],"gpt_icon":0},{"id":"2452392471","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘快速下跌9.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452392471","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452392471?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:31","pubTimestamp":1721395909,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时31分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅下挫9.24%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Silo Pharma, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为578.95%、214.59%、107.54%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Altamira Therapeutics Ltd.、Solid Biosciences Inc.，振幅分别为20.33%、8.96%、7.82%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071921314995dcfa96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071921314995dcfa96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2452995157","title":"Salarius Pharmaceuticals, Inc.盘中异动 大幅上涨8.39%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452995157","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452995157?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:36","pubTimestamp":1721223373,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时36分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅上涨8.39%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。其相关个股中，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为742.38%、532.66%、127.58%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.、Cytomed Therapeutics Limited，振幅分别为20.47%、19.03%、18.37%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172136139681da84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172136139681da84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRX"],"gpt_icon":1},{"id":"2451913330","title":"Salarius Pharmaceuticals, Inc.盘中异动 股价大涨5.06%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451913330","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451913330?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:56","pubTimestamp":1721138205,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时56分，Salarius Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.06%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1742.74%、993.37%、93.53%，振幅较大的相关个股有Scisparc Ltd.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、40.19%、39.04%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215646af9299e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215646af9299e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRX"],"gpt_icon":0},{"id":"2451162632","title":"Salarius Pharmaceuticals, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451162632","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451162632?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:19","pubTimestamp":1721053180,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时19分，Salarius Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.05%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Scinai Immunotherapeutics Ltd、Aeon Biopharma, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为2782.04%、111.10%、76.54%，振幅较大的相关个股有Aeon Biopharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Scinai Immunotherapeutics Ltd，振幅分别为76.07%、74.53%、60.34%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715221940af926655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715221940af926655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2450125535","title":"Salarius Pharmaceuticals, Inc.盘中异动 股价大跌7.34%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450125535","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450125535?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:35","pubTimestamp":1720791327,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时35分，Salarius Pharmaceuticals, Inc.股票出现异动，股价急速跳水7.34%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Zura Bio Limited C/Wts 、Qualigen Therapeutics, Inc.、Immutep Ltd涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为662.60%、79.45%、25.14%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Engene Holdings Inc.，振幅分别为21.43%、20.00%、14.29%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213528af921ccb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213528af921ccb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2450526753","title":"BUZZ-Salarius Pharma 因 FDA 将癌症药物试验部分临床搁置而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2450526753","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450526753?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:52","pubTimestamp":1720702355,"startTime":"0","endTime":"0","summary":"    7月11日 - ** 药物开发商Salarius Pharmaceuticals   股价盘前下跌20.8%至2.17美元** 该公司称， ，美国食品和药物管理局已部分暂停了该公司实验性药物seclidemstat与化疗药物阿扎胞苷联合治疗成年血癌患者的早期临床试验。** 公司打算支持 MDACC 的研究人员分析现有数据，并对 FDA 提出的问题做出回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLRX","BUZZ"],"gpt_icon":0},{"id":"2450815994","title":"Salarius Pharmaceuticals, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450815994","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450815994?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:56","pubTimestamp":1720619786,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时56分，Salarius Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.26%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为2027.78%、946.57%、585.84%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.，振幅分别为119.83%、62.50%、59.23%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710215627941f5d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710215627941f5d68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SLRX","VRPX","LGVN"],"gpt_icon":0},{"id":"2450236250","title":"Salarius Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450236250","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450236250?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:02","pubTimestamp":1720533762,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时02分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.04%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、Anew Medical Inc C/Wts 21/06/2029 涨幅较大，Soligenix, Inc.、Anew Medical, Inc.、Longeveron Inc.较为活跃，换手率分别为5005.55%、121.27%、95.31%，振幅较大的相关个股有Soligenix, Inc.、Longeveron Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为167.50%、38.02%、33.17%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220243941f570e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220243941f570e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","SLRX","BK4139"],"gpt_icon":0},{"id":"2449705242","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449705242","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449705242?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:57","pubTimestamp":1720447022,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时57分，Salarius Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.00%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Morphic Holding, Inc.、Virpax Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为757.24%、159.98%、131.60%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为65.74%、36.60%、33.33%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082157029f1f0315&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082157029f1f0315&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRX","BK4007","VRPX"],"gpt_icon":0},{"id":"2448423195","title":"Salarius Pharmaceuticals, Inc.盘中异动 下午盘股价大涨7.47%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448423195","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448423195?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:24","pubTimestamp":1719948241,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时24分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅拉升7.47%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd.涨幅较大，Annovis Bio, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为323.72%、70.64%、63.97%，振幅较大的相关个股有Annovis Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为151.42%、72.83%、53.12%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030324019ef69781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030324019ef69781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS","SLRX"],"gpt_icon":0},{"id":"2448143839","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大跌7.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448143839","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448143839?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:58","pubTimestamp":1719845910,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时58分，Salarius Pharmaceuticals, Inc.股票出现异动，股价大幅下挫7.56%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为552.53%、143.90%、100.99%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、65.56%、51.91%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701225830af900a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701225830af900a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRX"],"gpt_icon":0},{"id":"2446395478","title":"Salarius Pharmaceuticals, Inc.盘中异动 股价大涨6.12%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446395478","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446395478?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:31","pubTimestamp":1719408695,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时31分，Salarius Pharmaceuticals, Inc.股票出现异动，股价快速上涨6.12%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为278.21%、59.80%、58.24%，振幅较大的相关个股有Anew Medical, Inc.、Atossa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为33.00%、20.87%、19.51%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621313695da6d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621313695da6d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2446793844","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘大幅拉升7.43%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446793844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446793844?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:04","pubTimestamp":1719324246,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时04分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅拉升7.43%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。其相关个股中，Senti Biosciences, Inc.、Glycomimetics, Inc.、Effector Therapeutics, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为135.08%、130.89%、79.11%，振幅较大的相关个股有Glycomimetics, Inc.、Senti Biosciences, Inc.、Werewolf Therapeutics, Inc.，振幅分别为30.68%、29.88%、29.12%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625220407af8f2176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625220407af8f2176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2445244130","title":"Salarius Pharmaceuticals, Inc.盘中异动 大幅跳水5.13%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445244130","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445244130?lang=zh_cn&edition=full","pubTime":"2024-06-21 00:43","pubTimestamp":1718901783,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日00时43分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.13%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621004303aef5ddfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621004303aef5ddfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2444167074","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.65%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444167074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444167074?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631065,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.65%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Xtl生物制药涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Longeveron Inc.较为活跃，换手率分别为2089.86%、353.33%、56.36%，振幅较大的相关个股有Mustang Bio, Inc.、Annovis Bio, Inc.、Sellas Life Sciences Group, Inc.，振幅分别为8.23%、4.70%、4.00%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213105941eef50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213105941eef50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRX"],"gpt_icon":0},{"id":"2443156679","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大跌15.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443156679","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443156679?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:42","pubTimestamp":1718376123,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时42分，Salarius Pharmaceuticals, Inc.股票出现异动，股价快速下挫15.82%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Cns Pharmaceuticals, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Longeveron Inc.、Cns Pharmaceuticals, Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为909.71%、675.59%、208.54%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为129.28%、57.51%、54.75%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061422420496814558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061422420496814558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRX"],"gpt_icon":0},{"id":"2443684603","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘快速下挫6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443684603","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443684603?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:14","pubTimestamp":1718288070,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时14分，Salarius Pharmaceuticals, Inc.股票出现异动，股价急速下挫6.29%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Clene Inc C/Wts 30/12/2025 、Longeveron Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Biorestorative Therapies, Inc.、Longeveron Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为1018.31%、864.43%、106.22%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Longeveron Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为74.62%、57.45%、49.23%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061322143096814067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061322143096814067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","SLRX","BK4139"],"gpt_icon":0},{"id":"2442392642","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442392642","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442392642?lang=zh_cn&edition=full","pubTime":"2024-06-11 22:04","pubTimestamp":1718114642,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日22时04分，Salarius Pharmaceuticals, Inc.股票出现异动，股价快速上涨6.00%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611220402aef45c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611220402aef45c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2439575031","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.30%报0.498美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439575031","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439575031?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:42","pubTimestamp":1716993724,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时42分，Salarius Pharmaceuticals, Inc.股票出现异动，股价大幅拉升7.30%。截至发稿，该股报0.498美元/股，成交量3.2599万股，换手率0.68%，振幅2.33%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529224204941eae98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529224204941eae98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.salariuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0758},{"period":"1month","weight":-0.3876},{"period":"3month","weight":-0.5361},{"period":"6month","weight":-0.6172},{"period":"1year","weight":-0.7901},{"period":"ytd","weight":-0.6481}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Salarius Pharmaceuticals, Inc.是一家于2014年2月26日在特拉华州注册成立的生物技术公司，并且其业务主要发生在马萨诸塞州的波士顿。该公司正在开发用于夜间腿抽筋和痉挛，并伴有严重的神经肌肉条件相关的创新和专有治疗。该公司认为，激活某些受体的初级感觉神经元减少了重复放电，或过度兴奋，α-运动神经元，从而防止或减少肌肉痉挛和抽搐的频率和强度。该公司还认为，它是唯一一家开发基于肌肉抽筋，痉挛抑制这种机制的产品的公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.005639},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000908},{"month":3,"riseRate":0.5,"avgChangeRate":0.031094},{"month":4,"riseRate":0.2,"avgChangeRate":-0.075189},{"month":5,"riseRate":0.5,"avgChangeRate":-0.013003},{"month":6,"riseRate":0.5,"avgChangeRate":-0.069204},{"month":7,"riseRate":0.2,"avgChangeRate":-0.147404},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.0579},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.099422},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.176615},{"month":11,"riseRate":0.444444,"avgChangeRate":0.02063},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.085424}],"exchange":"NASDAQ","name":"Salarius Pharmaceuticals Inc","nameEN":"Salarius Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Salarius Pharmaceuticals Inc(SLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Salarius Pharmaceuticals Inc(SLRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Salarius Pharmaceuticals Inc,SLRX,Salarius Pharmaceuticals Inc股票,Salarius Pharmaceuticals Inc股票老虎,Salarius Pharmaceuticals Inc股票老虎国际,Salarius Pharmaceuticals Inc行情,Salarius Pharmaceuticals Inc股票行情,Salarius Pharmaceuticals Inc股价,Salarius Pharmaceuticals Inc股市,Salarius Pharmaceuticals Inc股票价格,Salarius Pharmaceuticals Inc股票交易,Salarius Pharmaceuticals Inc股票购买,Salarius Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Salarius Pharmaceuticals Inc(SLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Salarius Pharmaceuticals Inc(SLRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}